Biocon Biologics recently announced that it would manufacture and supply insulin glargine pens to Civica under a multi-year ...

The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...

California Gov. Gavin Newsom, a leading Democratic critic of President Donald Trump, says he'll consider running for the ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell an affordable version of the drug to residents, Gov. Gavin Newsom announced ...

California Gov. Gavin Newsom announces CalRx-branded insulin glargine pens available beginning Jan. 1, 2026, at a suggested retail price of no more than $55 per five-pack, or $11 per pen, during a ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom.Beginning Jan. 1, 2026, CalRx-branded ...